Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

24.76
+0.92003.86%
Post-market: 24.50-0.2600-1.05%19:07 EDT
Volume:1.01M
Turnover:24.98M
Market Cap:5.04B
PE:-9.24
High:25.17
Open:24.28
Low:24.26
Close:23.84
52wk High:29.25
52wk Low:12.72
Shares:203.53M
Float Shares:89.02M
Volume Ratio:0.54
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6799
EPS(LYR):-2.7303
ROE:-69.35%
ROA:-41.33%
PB:5.11
PE(LYR):-9.07

Loading ...

Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
May 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 29, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Correspondence

Form CORRESP - Correspondence
Feb 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]